遅発性ジスキネジア(Tardive Dyskinesia):世界の治験レビュー(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Tardive Dyskinesia Global Clinical Trials Review, H1, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Tardive Dyskinesia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Tardive Dyskinesia to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Tardive Dyskinesia to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Tardive Dyskinesia 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Tardive Dyskinesia Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Tardive Dyskinesia 31
Feb 03, 2015: Auspex Pharmaceuticals Completes Enrollment in a Pivotal Clinical Trial of SD-809 in Tardive Dyskinesia 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Neurocrine Biosciences, Inc. 32
Clinical Trial Overview of Neurocrine Biosciences, Inc. 32
Teva Pharmaceutical Industries Limited 33
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 33
UCB S.A. 34
Clinical Trial Overview of UCB S.A. 34
Synchroneuron Inc. 35
Clinical Trial Overview of Synchroneuron Inc. 35
Medicure Inc. 36
Clinical Trial Overview of Medicure Inc. 36
Clinical Trial Overview of Top Institutes / Government 37
Beersheva Mental Health Center 37
Clinical Trial Overview of Beersheva Mental Health Center 37
Beijing Huilongguan Hospital 38
Clinical Trial Overview of Beijing Huilongguan Hospital 38
Taoyuan Mental Hospital 39
Clinical Trial Overview of Taoyuan Mental Hospital 39
Baylor College of Medicine 40
Clinical Trial Overview of Baylor College of Medicine 40
Ben-Gurion University of the Negev 41
Clinical Trial Overview of Ben-Gurion University of the Negev 41
Centre for Addiction and Mental Health 42
Clinical Trial Overview of Centre for Addiction and Mental Health 42
Centre Hospitalier Universitaire, Amiens 43
Clinical Trial Overview of Centre Hospitalier Universitaire, Amiens 43
Herzog Hospital 44
Clinical Trial Overview of Herzog Hospital 44
Lawson Health Research Institute 45
Clinical Trial Overview of Lawson Health Research Institute 45
Parnassia Psycho Medical Centre 46
Clinical Trial Overview of Parnassia Psycho Medical Centre 46
Five Key Clinical Profiles 47
Appendix 63
Abbreviations 63
Definitions 63
Research Methodology 64
Secondary Research 64
About GlobalData 65
Contact Us 65
Disclaimer 65
Source 65


【レポート販売概要】

■ タイトル:遅発性ジスキネジア(Tardive Dyskinesia):世界の治験レビュー(2015年上半期版)
■ 英文:Tardive Dyskinesia Global Clinical Trials Review, H1, 2015
■ 発行日:2015年4月17日
■ 調査会社:GlobalData
■ 商品コード:GDHC2627CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。